2B4 Acts As a Non–Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells
Open Access
- 3 May 2004
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 199 (9), 1245-1254
- https://doi.org/10.1084/jem.20031989
Abstract
Natural killer (NK) cells are critical in the immune response to tumor cells, virally infected cells, and bone marrow allografts. 2B4 (CD244) is expressed on all NK cells and the ligand for 2B4, CD48, is expressed on hematopoietic cells. Cross-linking 2B4 on NK cells with anti-2B4 monoclonal antibody leads to NK cell activation in vitro. Therefore, 2B4 is considered to be an activating receptor. Surprisingly, we have found, using antibody-blocking and 2B4-deficient NK cells, that NK lysis of CD48+ tumor and allogeneic targets is inhibited by 2B4 ligation. Interferon γ production by NK cells is also inhibited. Using a peritoneal tumor clearance assay, it was found that 2B4−/− mice have increased clearance of CD48+ tumor cells in vivo. Retroviral transduction of 2B4 was sufficient to restore inhibition in 2B4−/− primary NK cells. It was found that although mature NK cells express SH2D1A, in vitro–derived NK cells do not. However, both populations are inhibited by 2B4 ligation. This indicates that 2B4 inhibitory signaling occurs regardless of the presence of SH2D1A. These findings reveal a novel role for 2B4 as a non–major histocompatibility complex binding negative regulator of NK cells.Keywords
This publication has 59 references indexed in Scilit:
- Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptorsNature Immunology, 2003
- Enhanced Antitumor Immunity in Mice Deficient in CD69The Journal of Experimental Medicine, 2003
- Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK CellsThe Journal of Experimental Medicine, 2002
- Plat-E: an efficient and stable system for transient packaging of retrovirusesGene Therapy, 2000
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- NK CELL RECEPTORSAnnual Review of Immunology, 1998
- Both Human α/β and γ Interferons Upregulate the Expression of CD48 Cell Surface MoleculesJournal of Interferon & Cytokine Research, 1997
- Triggering of Natural Killer Cells by the Costimulatory Molecule CD80 (B7-1)Immunity, 1996
- The role of natural killer cells in transplantationCurrent Opinion in Immunology, 1995
- CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.The Journal of Experimental Medicine, 1991